Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Harry_Lamble
|
| gptkbp:developedBy |
instrument-free molecular diagnostic tests
|
| gptkbp:focusesOn |
molecular diagnostics
|
| gptkbp:foundedIn |
2014
|
| gptkbp:fundedBy |
gptkb:Mercia_Asset_Management
gptkb:Cambridge_Innovation_Capital gptkb:Amadeus_Capital_Partners gptkb:Earlybird_Venture_Capital gptkb:Jonathan_Milner |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sense Biodetection
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:offers |
COVID-19 diagnostic tests
Flu diagnostic tests |
| gptkbp:product |
gptkb:Veros_platform
|
| gptkbp:specializesIn |
point-of-care testing
|
| gptkbp:targetMarket |
healthcare providers
clinical laboratories |
| gptkbp:technology |
isothermal amplification
|
| gptkbp:website |
https://sense-bio.com/
|
| gptkbp:bfsParent |
gptkb:Cambridge_Innovation_Capital
|
| gptkbp:bfsLayer |
6
|